I'm surprised this is trading above cash backing. Losing $2m a quarter. What does the market see that I don't?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025